Aurobindo Pharma Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Net Sales

9,150.35

8,853.34

8,645.90

8,285.70

7,868.14

8,382.12

7,978.52

Other Operating Income

0.00

Total Operating income

9,150.35

8,853.34

8,645.90

8,285.70

7,868.14

8,382.12

7,978.52

Raw Material Cost

2,894.40

2,505.35

2,754.88

2,509.80

2,535.16

2,799.51

2,728.74

Purchase of Finished goods

931.78

931.48

892.65

846.05

807.80

636.18

823.89

(Increase) / Decrease In Stocks

-199.23

-7.76

-166.32

-16.99

-103.74

-7.81

-237.22

Employee Cost

1,480.15

1,373.98

1,310.06

1,277.33

1,228.80

1,162.64

1,131.55

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,162.19

2,297.51

2,081.29

1,991.41

1,797.09

1,999.68

1,953.58

Total Expenditure (Excl Depreciation)

7,269.29

7,100.56

6,872.56

6,607.60

6,265.11

6,590.20

6,400.54

Operating Profit (PBDIT) excl Other Income

1,881.06

1,752.78

1,773.34

1,678.10

1,603.03

1,791.92

1,577.98

Other Income

264.23

117.04

187.64

120.59

105.30

134.81

157.29

Operating Profit (PBDIT)

2,145.29

1,869.82

1,960.98

1,798.69

1,708.33

1,926.73

1,735.27

Interest

101.66

98.21

92.77

95.24

97.75

115.02

118.48

Exceptional Items

-40.18

0.00

-65.33

0.00

Gross Profit (PBDT)

2,003.45

1,771.61

1,802.88

1,703.45

1,610.58

1,811.71

1,616.79

Depreciation

486.82

478.57

464.73

429.19

405.70

444.43

418.53

Profit Before Tax

1,515.09

1,290.61

1,338.52

1,275.92

1,206.80

1,335.09

1,199.85

Tax

483.06

369.77

428.72

427.79

382.60

432.26

354.28

Provisions and contingencies

0.00

Profit After Tax

1,033.57

923.27

909.43

846.47

822.28

935.02

843.98

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,033.57

923.27

909.43

846.47

822.28

935.02

843.98

Share in Profit of Associates

-1.54

-2.43

0.37

1.66

1.92

-32.19

1.59

Minority Interest

-0.53

-0.42

-0.49

-0.32

-0.55

-0.64

-0.24

Other related items

0.00

Consolidated Net Profit

1,032.56

921.26

910.29

848.45

824.75

903.47

845.81

Equity Capital

57.54

58.08

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

17.95

15.86

15.67

14.61

14.2

15.56

14.56

Diluted Earnings per share

17.86

15.86

15.67

14.61

14.2

15.56

14.56

Operating Profit Margin (Excl OI)

20.66%

20.03%

20.61%

20.37%

20.57%

21.38%

19.99%

Gross Profit Margin

22.0%

20.24%

20.95%

20.68%

20.67%

21.62%

20.48%

PAT Margin

11.33%

10.52%

10.57%

10.3%

10.58%

10.77%

10.71%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 3.35% vs 2.40% in Mar 2026

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 12.08% vs 1.21% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 7.32% vs -1.16% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 3.51% vs 5.86% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Aurobindo Pharma With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

9,150.35

8,099.80

1,050.55

12.97%

Other Operating Income

0.00

Total Operating income

9,150.35

8,099.80

1,050.55

12.97%

Raw Material Cost

2,894.40

1,653.80

1,240.60

75.02%

Purchase of Finished goods

931.78

1,973.80

-1,042.02

-52.79%

(Increase) / Decrease In Stocks

-199.23

-242.50

43.27

17.84%

Employee Cost

1,480.15

1,651.60

-171.45

-10.38%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,162.19

2,203.20

-41.01

-1.86%

Total Expenditure (Excl Depreciation)

7,269.29

7,239.90

29.39

0.41%

Operating Profit (PBDIT) excl Other Income

1,881.06

859.90

1,021.16

118.75%

Other Income

264.23

354.70

-90.47

-25.51%

Operating Profit (PBDIT)

2,145.29

1,214.60

930.69

76.63%

Interest

101.66

125.50

-23.84

-19.00%

Exceptional Items

-40.18

0.00

-40.18

Gross Profit (PBDT)

2,003.45

1,089.10

914.35

83.95%

Depreciation

486.82

536.60

-49.78

-9.28%

Profit Before Tax

1,515.09

553.30

961.79

173.83%

Tax

483.06

117.70

365.36

310.42%

Provisions and contingencies

0.00

Profit After Tax

1,033.57

434.80

598.77

137.71%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,033.57

434.80

598.77

137.71%

Share in Profit of Associates

-1.54

0.80

-2.34

-292.50%

Minority Interest

-0.53

-8.70

8.17

93.91%

Other related items

0.00

Consolidated Net Profit

1,032.56

444.30

588.26

132.40%

Equity Capital

57.54

83.50

-25.96

-31.09%

Face Value

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

17.95

5.32

12.63

237.41%

Diluted Earnings per share

17.86

5.33

12.53

235.08%

Operating Profit Margin (Excl OI)

20.66%

10.65%

0.00

10.01%

Gross Profit Margin

22.00%

13.49%

0.00

8.51%

PAT Margin

11.33%

5.40%

0.00

5.93%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 9,150.35 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 3.35% vs 2.40% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 16.30% vs 3.98% in Jun 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 1,032.56 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 12.08% vs 1.21% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 25.20% vs -10.28% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,881.06 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 7.32% vs -1.16% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 17.34% vs -1.02% in Jun 2025

Quarterly - Interest

Interest 101.66 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 3.51% vs 5.86% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 4.00% vs -11.97% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.66%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025